Abbott Completes Separation of Research-Based Pharmaceuticals Business
date:Jan 04, 2013
geographically, with 30 percent generated in the United States, 30 percent from Western Europe, Canada, Japan and Australia, and 40 percent from the fastest-growing economies, including India, China, Russia and Brazil. The company's presence in these high-growth markets is among the most expansive of any diversified healthcare company and is expected to reach nearly 50 percent of sales by 2015.
7/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/06 19:58